REFERENCES
- Weih L M, Van Newkirk M R, McCarty C A, et al. Age-specific causes of bilateral visual impairment. Arch Ophthalmol. 2000; 118: 264–269, [PUBMED], [INFOTRIEVE], [CSA]
- Quigley H A. Number of people with glaucoma worldwide. BJ Ophthalmol. 1996; 80: 389–393, [CSA]
- Wensor M D, McCarty C A, Stanislavsky Y L, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmol. 1998; 105: 733–739, [CSA]
- Quigley H A, Park C K, Tracey P A, Pollack I P. Community screening for eye disease by laypersons: The Hoffberger Program. Am J Ophthalmol. 2002; 133: 386–392, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Alward W A. Frequency Doubling Technology perimetry for the detection of glaucomatous visual field loss. Am J Ophthalmol. 2000; 129: 376–378, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weih L, Sakellariou Rait J, et al. Performance of Frequency Doubling Perimetry in screening for glaucoma [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2000; 41(4), Abstract NR 2537
- World Medical Association Declaration of Helsinki. Amended at the 52nd WMA General Assembly, EdinburghScotland, 2000, Available from: http://www.med.or.jp/english/helsin_e.html
- Ferris F L, 3rd, Sperduto R D. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol. 1982; 94: 97–98, [PUBMED], [INFOTRIEVE]
- Johnson C A, Samuels S J. Screening for glaucomatous visual field loss with Frequency-Doubling Perimetry. Invest Ophthalmol Vis Sci. 1997; 38: 413–425, [PUBMED], [INFOTRIEVE], [CSA]
- Wollstein G, Garway-Heath D F, Hitchings R A. Identification of early glaucoma cases with the scanning laser ophthalmoscope. Ophthalmol. 1998; 105: 1557–1563, [CSA]
- Sponsel W E, Arango S, Trigo Y, Mensah J. Clinical classification of glaucomatous visual field loss by frequency doubling perimetry. Am J Ophthalmol. 1998; 125: 830–836, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quigley H A. Identification of glaucoma-related visual field abnormality with the screening protocol of Frequency Doubling Technology. Am J Ophthalmol. 1998; 125: 819–829, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paczka J A, Friedman D S, Quigley H A, et al. Diagnostic capabilities of frequency-doubling technology, scanning laser polarimetry, and nerve fiber layer photographs to distinguish glaucomatous damage. Am J Ophthalmol. 2001; 131: 188–197, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Allen C S, Sponsel W E, Trigo Y, et al. Comparison of the Frequency Doubling Technology screening algorithm and the Humphrey 24-2 SITA-FAST in a large eye screening. Clin Experiment Ophthalmol. 2002; 30: 8–14, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Visual field test scoring and reliability. Ophthalmol. 1994; 101: 1445–1455, [The Advanced Glaucoma Intervention Study Investigators] Advanced Glaucoma Intervention Study. 2
- Burnstein Y, Ellish N J, Magbalon M, et al. Comparison of Frequency Doubling Perimetry with Humphrey Visual Field analysis in a glaucoma practice. Am J Ophthalmol. 2000; 129: 328–333, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yamada N, Chen P P, Mills R P, et al. Screening for glaucoma with Frequency-Doubling Technology and Damato Campimetry. Arch Ophthalmol. 1999; 117: 1479–1484, [PUBMED], [INFOTRIEVE], [CSA]
- Shields M B. The challenge of screening for glaucoma. Am J Ophthalmol. 1995; 120: 793–795, [PUBMED], [INFOTRIEVE], [CSA]
- Sponsel W E, Trigo Y, Hendricks J, Lloyd C. Frequency Doubling Perimetry. Am J Ophthalmol. 1998; 126: 155–156, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thomas D, Thomas R, Muliyil J P, et al. Role of Frequency Doubling Perimetry in detecting neuro-ophthalmic visual field defects. Am J Ophthalmol. 2001; 131: 734–741, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Harper R A, Reeves B C. Glaucoma screening: The importance of combining test data. Opton Vis Sci. 1999; 76: 537–543, [CSA]
- Michelson G, Groh M JM. Screening models for glaucoma. Curr Opin Ophthalmol. 2001; 12: 105–111, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bathija R, Zangwill L, Berry C C, et al. Detection of early glaucomatous structural damage with confocal laser tomography. J Ophthalmol. 1997; 7: 121–127
- Nemesure B, Leske M C, He Q, et al. Analyses of reported family history of glaucoma: A preliminary investigation. Ophthalmic Epidemiol. 1996; 3: 135–141, [PUBMED], [INFOTRIEVE], [CSA]
- Mitchell P, Rochtchina E, Lee A J, Wang J J. Bias in self-reported family history and relationship to glaucoma: The Blue Mountains Eye Study. Ophthalmic Epidemiol. 2002; 9: 333–345, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tielsch J M, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. Arch Ophthalmol. 1994; 112: 69–73, [PUBMED], [INFOTRIEVE]
- Weih L M, Nanjan M, McCarty C, et al. Prevalence and predictors of open-angle glaucoma. Ophthalmol. 2001; 108: 1996–1972
- Leske M C, Connell A MS, Wu S, et al. Risk factors for open-angle glaucoma. Arch Ophthalmol. 1995; 113: 918–924, [PUBMED], [INFOTRIEVE], [CSA]
- Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol. 1996; 7: 93–98, [PUBMED], [INFOTRIEVE], [CSA]